FREEDOM COVID: Full-Dose Anticoagulation Cut Mortality
In an in-hospital anticoagulation trial, the primary COVID endpoint was missed, but a survival benefit was observed.
MDedge News
source https://www.medscape.com/viewarticle/989565?src=rss
MDedge News
source https://www.medscape.com/viewarticle/989565?src=rss
Comments
Post a Comment